Skip to main content
BMJ Open logoLink to BMJ Open
. 2025 Apr 29;15(4):e086945. doi: 10.1136/bmjopen-2024-086945

Clinical characteristics and outcomes of percutaneous coronary intervention in octogenarians: real-world data from nationwide Thai PCI registry

Supawat Ratanapo 1, Apichard Sukonthasarn 2, Pitha Promlikitchai 3, Kamonrat Thongplung 4, Ammarin Thakkinstian 5, Nakarin Sansanayudh 1,; Thai PCI Registry Working Group
PMCID: PMC12049939  PMID: 40306912

Abstract

Abstract

Objective

Due to the growing ageing population worldwide, more percutaneous coronary interventions (PCI) are being performed on elderly patients; however, current national data in Southeast Asian developing countries regarding patient characteristics, procedural details and PCI outcomes in elderly patients are insufficient.

Design

Observational study.

Setting

Nationwide registry from 39 primary PCI facilities across Thailand.

Participants

Between May 2018 and August 2019, the Thai PCI registry enrolled a total of 22 741 patients who underwent PCI. We examined patient characteristics, PCI technique and in-hospital outcomes in octogenarians (≥80 years) and non-octogenarians (18–79 years).

Results

There were 2099 patients (9.2%) over the age of 80. Octogenarians were at greater risk for atherosclerosis and calcified coronary lesions that required plaque modification and a higher risk of cardiogenic shock during presentation than non-octogenarians. The success rate of PCI in octogenarians was high (95.5%) and comparable to non-octogenarians (96%). The respective PCI failure rate in non-octogenarians and octogenarians was 4% and 4.5% (p=0.251). Octogenarians had a substantially greater incidence of periprocedural problems (5.6% vs 4.5%, p=0.011). PCI was linked with more than threefold increase in in-hospital mortality in octogenarians compared with non-octogenarians (7.67% vs 2.3%, p 0.001). Nonetheless, revascularisation with PCI in octogenarians increased the EQ-5D (European Quality of Life 5 Dimensions) score by 15.7 after PCI and before hospital discharge.

Conclusions

According to the Thai PCI registry, octogenarians had more complicated coronary anatomy, as well as higher procedural complications and mortality than non-octogenarians. Nonetheless, PCI in the octogenarian had a high success rate and potentially improved the patient’s quality of life.

Keywords: Aged, 80 and over; Coronary intervention; Cardiovascular Disease


STRENGTHS AND LIMITATIONS OF THIS STUDY.

  • The Thai percutaneous coronary intervention (PCI) registry is one of Southeast Asia’s largest nationwide PCI registries.

  • Real-world data reflected the contemporary PCI practices in the octogenarian population of developing countries

  • Given the nature of the registry, the study focused on the patients who only underwent PCI and excluded those who underwent coronary arterial bypass grafting or conservative medical therapy.

  • The rate of the radial approach was lower than the current trend of contemporary PCI compared with developed countries, which might affect the mortality and complication risk of PCI, such as bleeding risk.

  • The Thai PCI registry lacks patient frailty data, which might substantially influence patient outcomes.

Background

One of the most significant healthcare changes worldwide is population ageing. Improving primary care has resulted in a 4.4-year increase in life expectancy by 2040.1 Over the next three decades, developing Southeast Asian countries, including Thailand, are expected to see a 264.1% rise in the population aged 80 and older.2 According to the most recent figures, the average life expectancy in Thailand is 75 years for males and 79 years for women.3 4

Coronary artery disease (CAD) is one of the primary causes of morbidity and death in the aged population, with the majority of cases presenting with acute coronary syndrome.5 6 According to the National Health and Nutrition Examination Survey,7 the prevalence of symptomatic CAD increases with age, reaching 30.6% in men and 21.7% in women over 80. However, medical research has typically excluded this particular group,8 primarily those over 80 and older, described as ‘octogenarians’ or ‘extremely elderly’. There is disagreement on the optimum therapy management, standards and best practices for octogenarians.9 Percutaneous coronary intervention (PCI) becomes difficult for this demographic group as well. Both mortality and morbidity are much more significant in octogenarians than in non-octogenarian groups10 or even in individuals aged 75–80.11 12 In patients aged 80–84 years, the 30-day death rate rises to 31.2%.13 Ageing is thus associated with a more significant number of medical comorbidities and more complex CAD, such as left main CAD, multivessel CAD and left ventricular systolic dysfunction,14,16 leading to more complicated and high-risk PCIs.717,19 These comorbidities also obscure the diagnosis of acute myocardial infarction (MI) in 20% of people over the age of 85, which can delay treatment and worsen the outcomes following MI.20

The Thai National Registry of Percutaneous Coronary Interventions (TPCIR) obtained Thailand’s previous national PCI data on senior people in 2006–2007.21 22 According to that study, the death rate within 24 hours of admission was 5.3% among patients 75 years old. However, with the revolution in interventional cardiology practice and the fast expansion of PCI-capable institutions in Thailand, along with the expansion of the Thai national universal health coverage programme, a greater number of octogenarians have received PCI in the nation since then. Using data from the existing Thai PCI registry,23 the current study aims to examine the features, kinds of PCI procedures, and PCI results in the octogenarian group. Our findings would give current data on the standard of care, PCI practice and results leading to enhanced PCI quality in the senior population.

Methods

Study design

This was a descriptive comparative analysis of the Thai PCI registry database, which included 22 741 patients aged 18 and above who had PCI from May 2018 to August 2019. The Thai PCI registry is a multicentre prospective research launched by the Cardiac Intervention Association of Thailand, recruiting 39 institutions around Thailand.24 As necessary, the study was authorised by Thailand’s Central Research Ethics Committee (CREC) by the Foundation for Human Research Promotion in Thailand (COA-CREC 006/2018) (https://www.crecthailand.org), as well as the local Ethics Committee (EC) in some institutes if required for approval (online supplemental file).

After the written or verbal informed consent, all consecutive adult patients aged 18 years or older who got PCI at these participating facilities were recruited. Data on patient characteristics, procedure details, equipment, medication usage, complications and in-hospital outcomes were gathered; see the Thai PCI registry research design for additional information.24

Our research factor of interest was octogenarian versus non-octogenarian, defined as age 80 versus 18–79 years. The outcomes of interest were procedure failure, complications, quality of life improvement and in-hospital death. More than 50% residual stenosis following balloon angioplasty or more than 20% after stent implantation was considered procedure failure. Procedural complication was defined as any of the following: cardiogenic shock, heart failure, cerebrovascular accident, cardiac tamponade, acute kidney injury requiring haemodialysis, infection at the access site, anaemia requiring blood transfusion, clinically significant arrhythmia and respiratory failure requiring endotracheal intubation.

Statistical analysis

Patient characteristics (categorical and continuous) were summarised using frequencies and means (with SD). Univariate analyses comparing octogenarians and non-octogenarians used χ2 tests for categorical variables (age, sex, healthcare coverage, comorbidities) and t-tests for continuous variables. Similar analyses were used to compare the CAD presentation, PCI urgency, coronary lesion characteristics, PCI access site, use of intravascular imaging, use of physiological guidance, PCI treatment modalities, plaque modification and type of antiplatelet therapy. Univariate analysis also examined the association of octogenarian status and each covariate with outcomes (death, PCI complications, PCI success). Covariates with p<0.10 in univariate analysis were entered into a multivariate logistic regression model; backward stepwise selection using likelihood ratio tests retained only variables with p<0.05. All analyses were performed using STATA V.17.0, with p<0.05 indicating statistical significance.

Patient and public involvement

None

Results

Patient population

Octogenarians made up a total of 2099 (or 9.2%) of the 22 741 patients. Among the octogenarians, 1948 (92.8%) were aged 80–89, 151 (7.2%) were aged 90 or more (nonagenarians) and 11 were aged 100 or greater (centenarians). Univariate analyses showed that males outnumbered females in all age groups, but the proportion of females increased after menopause, from 7.1% in pre-menopause to 62.9% in post-menopause (age 50 years). Overall, the proportion of females in the octogenarian group outnumbered males by a wide margin (13.7% vs 7.2%) (figure 1).

Figure 1. Patients in the Thai PCI registry were categorised by sex and 10-year age intervals from 18 years to ≥90 years in the last patient group. The octogenarians (≥ 80 years) comprised 2099 (9.2%) of the 22 741 patients. Among the octogenarians, 1948 (92.8%) were aged 80–89, and 151 (7.2%) were aged ≥90 (nonagenarians). Males outnumbered females in all age groups, but the proportion of females significantly increased after menopause, from 7.1% in the pre-menopause to 62.9% in the post-menopause (≥50 years). The proportion of females in the octogenarian group was greater than males (13.7% vs 7.2%).

Figure 1

As expected, octogenarians had a higher prevalence of comorbidities and risk factors for atherosclerotic cardiovascular disease (ASCVD) (table 1). Octogenarians had a higher percentage of patients with prior surgical revascularisation (2.4% vs 1.6%, p=0.003), history of heart failure (21.1% vs 13%, p 0.001), hypertension (77.2% vs 66.4%, p 0.001) and history of cerebrovascular disease (8.6% vs 5.4%, p 0.001). Certain ASCVD risks were also approximately twofold higher in octogenarians than in non-octogenarians, such as a history of peripheral arterial disease (3.3% vs 1.5%, p 0.001), chronic lung disease (6.3% vs 3.0%, p 0.001) and chronic kidney disease with creatinine level more than 1.5 mg/dL or estimated GFR 60 mL/min/m2 (63.6% vs 29.4%, p<0.001).

Table 1. Baseline demographics of octogenarians compared with non-octogenarians in the Thai PCI registry (n=22 741).

Characteristic Octogenarian (age ≥80) Non-octogenarian (age 18–79) P value
N (%) N (%)
Number of patients 2099 (9.2) 20 642 (90.8)
Female 967 (46.1) 6070 (29.4) <0.001
Male 1132 (53.9) 14 569 (70.6)
Health coverage scheme
 Universal coverage 1131 (53.9) 13 218 (64.0) <0.001
 Government service/state enterprise 848 (40.4) 5258 (25.5)
 Social security service 10 (0.5) 1547 (7.5)
 Others 110 (5.2) 691 (3.0)
Obesity (BMI ≥23 kg/m2) 394 (18.8) 8359 (40.5) <0.001
Prior myocardial infarction 476 (22.7) 4891 (23.7) 0.298
Known CAD* 720 (34.3) 7004 (33.9) 0.729
Prior PCI 611 (29.1) 6126 (29.7) 0.587
Prior CABG 51 (2.4) 322 (1.6) 0.003
Heart failure 442 (21.1) 2689 (13.0) <0.001
Diabetes mellitus 826 (39.4) 9224 (44.7) <0.001
Hypertension 1620 (77.2) 13 703 (66.4) <0.001
Dyslipidaemia 1337 (63.7) 13 526 (65.5) 0.094
Cerebrovascular disease 181 (8.6) 1115 (5.4) <0.001
Peripheral arterial disease 70 (3.3) 319 (1.5) <0.001
Chronic lung disease 132 (6.3) 609 (3.0) <0.001
Chronic kidney disease 1335 (63.6) 6063 (29.4) <0.001
History of smoking 824 (39.3) 11 700 (56.7) <0.001
CAD presentation
 STEMI 566 (27.0) 5807 (28.1) <0.001
 NSTE-ACS 759 (36.1) 6047 (29.3)
 CCS 774 (36.9) 8788 (42.6)
Cardiogenic shock 250 (11.9) 1562 (7.6) <0.001
PCI status
 Elective 1204 (57.3) 12 722 (61.6) 0.001
 Urgent 356 (17) 3171 (15.4)
 Emergency 539 (25.7) 4749 (23)
*

Coronary stenosis >50%.

BMI, body mass index; CABG, coronary arterial bypass grafting; CAD, coronary artery disease; CCS, chronic coronary syndrome; NSTE-ACS, non-ST elevation acute coronary syndrome; PCI, percutaneous coronary intervention; PCI, percutaneous coronary intervention; STEMI, ST elevation myocardial infarction.

However, several risk factors for ASCVD were less in octogenarians, such as morbid obesity (18.8% vs 40.5%, p<0.001), diabetes mellitus (39.4% vs 44.7%, p<0.001), and history of smoking (39.3% vs 56.7%, p<0.001) in octogenarians and non-octogenarians, respectively.

Thailand’s universal health coverage scheme covered the majority of patients in both age groups. Octogenarians had more patients who used the government or state enterprise officer scheme for reimbursement (40.4% vs 25.7%) than non-octogenarians. Conversely, non-octogenarians used more social security schemes than octogenarians (7.5% vs 0.5%).

CAD presentation and lesion characteristics

Although univariate analysis showed that chronic coronary syndrome (CCS) was the most common indication for PCI in both age groups, 36.9% in octogenarians and 42.6% in non-octogenarians, older patients had a significantly higher rate of non-ST elevation acute coronary syndrome (NSTE-ACS) than the younger patients (36.1% vs 29.3%). Meanwhile, ST elevation myocardial infarction (STEMI) was 27% in octogenarians compared with 28.1% in non-octogenarians.

Notably, the Thai PCI registry found no significant variations in lesion type complexity between octogenarians and non-octogenarians based on the updated American College of Cardiology (ACC)/American Heart Association (AHA) categorisation of coronary lesions.25 In both age groups, more than 80% of the patients in this registry had complicated coronary lesions (types C and B2). The type C coronary lesion was the most prevalent lesion that underwent PCI, accounting for more than 60% of the patients in both groups, followed by type B2, type B1 and type A lesions with the prevalence of 18%, 15% and 4%, respectively (table 2).

Table 2. Lesion characteristics and procedural details of octogenarians compared with non-octogenarians in the Thai PCI registry (n=22 741).

Characteristic Octogenarian (age ≥80) Non-octogenarian (age 18–79) P value
N (%) N (%)
Coronary lesion characteristic*
 A 82 (3.9) 886 (4.3) 0.226
 B1 319 (15.3) 3030 (14.8)
 B2 538 (17.1) 3828 (18.6)
 C 1331 (63.7) 12 782 (62.3)
Ostial lesion 352 (13.5) 2842 (11.1) 0.001
Bifurcation lesion 334 (12.8) 3535 (13.9) 0.086
Previously treated lesion 146 (5.6) 1621 (6.3) 0.221
Need for IABP 121 (5.8) 651 (3.2) <0.001
Temporary pacemaker insertion during PCI 39 (1.9) 203 (1.0) <0.001
Initial access site
 Radial artery 714 (34.0) 9348 (45.3) <0.001
 Brachial artery 5 (0.2) 42 (0.2)
 Femoral artery 1345 (64.1) 10 854 (52.6)
 Combination approach 35 (1.7) 398 (1.9)
Imaging-guided PCI
 IVUS-guided PCI 334 (12.8) 3597 (14) 0.086
 OCT-guided PCI 12 (0.5) 257 (1.0) 0.053
Physiologic-guided PCI 31 (1.2) 475 (1.9) 0.074
PCI techniques
 Balloon angioplasty 234 (9) 2056 (8) 0.079
 DES 2308 (88.6) 22 906 (89.3) 0.347
 BMS 5 (0.2) 26 (0.1) 0.468
Plaque modification 185 (7.1) 1141 (4.5) <0.001
 Rotational atherectomy 96 (3.7) 460 (1.8) <0.001
 Cutting balloon angioplasty 20 (0.8) 177 (0.7) 0.646
 Laser angioplasty 0 (0.0) 17 (0.1) 0.204
Aspiration thrombectomy 161 (6.2) 1823 (7.1) 0.076
Ancillary medications
 Aspirin 2075 (98.9) 20 483 (99.2) 0.072
 P2Y12 inhibitors
  Clopidogrel 1965 (93.8) 19 018 (92.3) 0.014
  Ticagrelor 164 (8.0) 1849 (9.1) 0.081
  Prasugrel 8 (0.4) 382 (1.9) <0.001
 GP IIb/IIIa inhibitor 141 (6.9) 1250 (6.3) 0.248
*

Modified ACC/AHA lesion-specific classification of the primary target stenosis.

ACC/AHA, American College of Cardiology /American Heart Association; BMS, bare-metal stent; DES, drug-eluting stent; IABP, intra-aortic balloon pump; IVUS, intravascular ultrasound; OCT, optical coherence tomography; PCI, percutaneous coronary intervention.

PCI procedure characteristic

Univariate analysis showed that the femoral approach remained the primary arterial access route in both age groups, particularly in the octogenarian group, where it was nearly twice as common as radial access (64.1% vs 34%) (table 2). The radial approach was adopted substantially more frequently in non-octogenarians than octogenarians (45.3% vs 34%, respectively).

Even though the recommendations encourage imaging and physiological guidance for PCI operations, actual practice in Thailand revealed that it was not widespread among patients in both categories (table 2). Only 13.3% and 15% of PCI patients in octogenarians and non-octogenarians employed at least one imaging-guided PCI modality, and fewer than 2% of both groups used physiological-guided PCI, whereas the decision for angioplasty was the same. A drug-eluting stent (DES) was used in about 90% of all PCIs. Only 8–9% of total PCI procedures employed balloon angioplasty alone, and bare-metal stent (BMS) was seldom used in the present registry.

There were nearly twice as many plaque modifications in octogenarians as in non-octogenarians (7.1% vs 4.5%, p<0.001), with rotational atherectomy being the most common tool for severely calcified lesions (3.7% vs 1.8%, p<0.001) (table 2).

Clopidogrel, the most often used antiplatelet therapy during PCI, remains the most commonly used P2Y12 inhibitor, accounting for more than 90% of patients in both age groups (table 2). Patients in both groups comparably received ticagrelor (7.8% vs 9%, p=0.081), while prasugrel usage was considerably lower in octogenarians than in non-octogenarians (0.4% vs 1.9%, p<0.001). GP IIb/IIIa inhibitors and adjunctive antiplatelet therapy were used in less than 7% of participants in the registry.

PCI outcomes and complications

Given the high success rate of up to 95.5% in octogenarians, the two groups had no significant differences in procedural failure (4.5% vs 4.0%, p=0.251) as per a univariate analysis. However, the elderly had a greater rate of morbidity and death following PCI operations. PCI complications were more common in octogenarians than in non-octogenarians (5.6% vs 4.6%, p=0.011). Regarding the death rate, octogenarians outnumbered non-octogenarians (7.67% vs 2.3%, p 0.001). Cardiogenic shock, heart failure, cerebrovascular accident, cardiac tamponade, acute kidney injury requiring haemodialysis, infection at the access site, anaemia requiring blood transfusion, clinically significant arrhythmia and respiratory failure requiring endotracheal intubation were significantly more common in octogenarians than in non-octogenarians (table 3).

Table 3. PCI outcomes in octogenarians compared with non-octogenarians in the Thai PCI registry (n=22 741).

PCI outcome Octogenarian (age ≥80) Non-octogenarian (age 18–79) P value
N (%) N (%)
Procedural success
 PCI success 2490 (95.5) 24 620 (96) 0.251
 PCI failure 116 (4.5) 1020 (4.0)
Total in-hospital mortality 161 (7.67) 471 (2.3) 0.011
Procedural complications 146 (5.6) 1144 (4.5) <0.001
 Myocardial infarction 144 (6.9) 1231 (6.0) 0.1
 Cardiogenic shock (post-procedure) 278 (13.2) 1507 (7.3) <0.001
 Heart failure 413 (19.7) 2345 (11.4) <0.001
 Cerebrovascular disease within 24 hours after PCI 15 (0.7) 70 (0.3) 0.007
 Cardiac tamponade 8 (0.4) 28 (0.1) 0.015
 Renal complication requiring haemodialysis 18 (0.9) 101 (0.5) 0.026
 Vascular complications required treatment 8 (0.4) 61 (0.3) 0.497
 AV fistula 2 (0.1) 13 (0.1) 0.643
 Pseudoaneurysm 3 (0.1) 12 (0.1) 0.155
 Infection at the access site 18 (0.9) 86 (0.4) 0.004
 Need of blood transfusion 53 (2.5) 184 (0.9) <0.001
 Bleeding event within 72 hours 139 (6.6) 963 (4.7) <0.001
 Arrhythmia required treatment 108 (5.1) 689 (3.3) <0.001
  Need of cardioversion or defibrillation 39 (1.9) 268 (1.3) 0.034
  Temporary pacemaker 39 (1.9) 203 (1.0) <0.001
 Repeat coronary angiogram in the same visit 19 (1.1) 180 (1.0) 0.061
 Respiratory failure requiring ETT intubation 182 (8.7) 793 (3.8) <0.001

AV, arteriovenous; ETT, endotracheal tube; PCI, percutaneous coronary intervention.

After a multivariable logistic regression adjustment, octogenarians showed non-significant increases in procedural complication risk compared with the 60–79 and 45–59 years age groups (OR 1.1, 95% CI 0.9 to 1.4 and 1.2, 95% CI 0.9 to 1.5, respectively) (table 4). However, octogenarians had a significantly higher risk of death compared with patients aged <45 years (OR 7.3, 95% CI 3.4 to 15.6) and those aged 60–79 years (OR 2.1, 95% CI 1.6 to 2.7) (table 5).

Table 4. Factors associated with PCI procedural complications: a multivariate analysis from the Thai PCI registry.

Factors Procedural complication P value
OR (95% CI)
Age group
 Age≥80 1.2 (0.9 to 1.5) 0.158
 Age 60–79 1.1 (0.9 to 1.3) 0.125
 Age 45–59 1
 Age<45 1.5 (1.1 to 2.0) 0.01
Gender (female vs male) 1.2 (1.1 to 1.4) 0.002
Hypertension 0.8 (0.7 to 0.9) 0.001
Prior myocardial infarction 1.4 (1.3 to 1.7) <0.001
No myocardial infarction 1
Prior CABG 1.5 (1.0 to 2.3) 0.049
Cardiogenic shock 1.7 (1.4 to 2.1) <0.001
Need for IABP 1.5 (1.1 to 1.9) 0.004
Access site cross over 1.6 (1.2 to 2.1) 0.001
Respiratory failure requiring ETT intubation 1.7 (1.4 to 2.2) <0.001
Total volume of contrast, per 10 mL 1.0056(1.0046 to 1.0065) <0.001
PCI status (vs Elective)
 Emergency 1.8 (1.5 to 2.1) <0.001
 Urgent 1.5 (1.3 to 1.8) <0.001
GP IIb/IIIa inhibitor 1.9 (1.6 to 2.3) <0.001
Lesion complexity* (vs type A)
 C 2.1 (1.4 to 3.2) <0.001
 B2 1.6 (1.1 to 2.5) 0.027
 B1 1.0 (0.6 to 1.5) 0.865
*

Modified ACC/AHA lesion-specific classification of the primary target stenosis.

ACC/AHA, American College of Cardiology (ACC)/American Heart Association (AHA) ; CABG, coronary arterial bypass grafting; ETT, endotracheal tube; IABP, intra-aortic balloon pump; PCI, percutaneous coronary intervention.

Table 5. Factors associated with death: a multivariate analysis from the Thai PCI registry.

Factors Procedural complication P value
OR (95% CI)
Age group
 Age≥80 7.3 (3.4 to 15.6) <0.001
 Age 60–79 3.5 (1.7 to 7.3) 0.001
 Age 45–59 2.4 (1.1 to 5.0) 0.023
 Age<45 1
Gender (female vs male) 1.3 (1.1 to 1.7) 0.006
Referral case from other centres 0.5 (0.4 to 0.6) <0.001
Chronic kidney disease 2.1 (1.7 to 2.6) <0.001
Diabetes mellitus 1.1 (0.9 to 1.4) 0.273
Initial access site (vs radial artery)
 Brachial artery 2.6 (0.3 to 20.2) 0.356
 Femoral artery 1.4 (1.1 to 1.8) 0.011
 Combination approach 2.0 (1.1 to 3.5) 0.018
Vital sign on admission
 Admission HR, per 10 bpm 1.14 (1.09 to 1.19) <0.001
 Admission SBP, per 5 mm Hg 0.95 (0.93 to 0.97) <0.001
Dyslipidaemia 0.7 (0.6 to 0.9) 0.001
Peripheral arterial disease 2.0 (1.2 to 3.5) 0.013
CAD presentation (vs CCS)
 STEMI 2.8 (1.7 to 4.6) <0.001
 NSTE-ACS 2.0 (1.3 to 3.2) 0.002
Number of severely diseased vessel (vs SVD)
 Left main disease 1.6 (1.1 to 2.1) 0.005
 TVD 1.0 (0.7 to 1.3) 0.921
 DVD 1.1 (0.8 to 1.4) 0.588
Cardiogenic shock 2.4 (1.9 to 3.1) <0.001
PCI status (vs elective PCI)
 Emergency 3.4 (2.2 to 5.2) <0.001
 Urgent 2.9 (1.9 to 4.3) <0.001
Respiratory failure requiring ETT intubation 5.2 (4.1 to 6.6) <0.001
Renal complication requiring haemodialysis 2.7 (1.6 to 4.3) <0.001
Need for IABP 2.8 (2.2 to 3.6) <0.001
Arrhythmia (vs no arrhythmia)
 Arrhythmia required treatment 2.0 (1.5 to 2.6) <0.001
 Arrhythmia without treatment 1.5 (1.0 to 2.4) 0.053
Procedural failure 2.3 (1.6 to 3.2) <0.001
Procedure complications 1.8 (1.3 to 2.4) <0.001

CAD, coronary artery disease; CCS, chronic coronary syndrome; DVD, double-vessel disease; ETT, endotracheal tube; HR, heart rate; IABP, intra-aortic balloon pump; NSTE-ACS, non-ST elevation acute coronary syndrome; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; STEMI, ST elevation myocardial infarction; SVD, single-vessel disease; TVD, triple-vessel disease.

Pre-discharge management

The majority of patients in the registry were sent home on dual antiplatelet treatments, such as aspirin and clopidogrel (table 6). Aspirin was taken less frequently for octogenarians than non-octogenarians (94.1% vs 97.8%, p 0.001). Potent P2Y12 inhibitors such as ticagrelor and prasugrel were used more regularly in non-octogenarians, although in a smaller proportion, less than 10%. Warfarin was used more than novel oral anticoagulants in octogenarians who needed anticoagulants. Non-octogenarians were more likely to be prescribed statins, beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers as adjuvant pharmacological treatments for cardiovascular disorders.

Table 6. Post PCI care and patient quality of life of octogenarians compared with non-octogenarians in the Thai PCI registry (n=22 741).

Post PCI care and patient quality of life Octogenarian (age ≥80) Non-octogenarian (age 18–79) P value
N (%) N (%)
Antiplatelet therapy
 Aspirin 1876 (94.1) 19 880 (97.8) <0.001
 Clopidogrel 1659 (83.2) 16 204 (79.7) <0.001
 Ticagrelor 203 (10.2) 2980 (14.7) <0.001
 Prasugrel 21 (1.1) 615 (3.0) <0.001
Vitamin K antagonist 64 (3.2) 476 (2.3) 0.016
NOAC 38 (1.9) 165 (0.8) <0.001
Statin 1781 (89.4) 18 979 (93.3) <0.001
Beta blocker 1088 (54.6) 12 569 (61.8) <0.001
ACEI or ARBs 813 (40.8) 10 299 (50.7) <0.001
Cardiac rehabilitation referral 670 (31.9) 7858 (43.6) <0.001
Patient quality of life
 EQ-5D before PCI, mean (SD) 61.8 (19.0) 67.0 (19.3) <0.001
 EQ-5D after PCI, before discharge, mean (SD) 77.5 (14.6) 82.6 (17.7) <0.001

ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; EQ-5D, European Quality of Life 5 Dimensions score; NOAC, novel oral anticoagulant; PCI, percutaneous coronary intervention.

After being discharged, less than 40% of PCI patients were referred for cardiac rehabilitation, and the elderly were less likely to be recommended for this treatment. However, patient quality of life, as measured by the mean EQ-5D (European Quality of Life 5 Dimensions) score,26 improved comparably in octogenarians and non-octogenarians following PCI (15.7 and 15.6, respectively) (table 6).

Discussion

The Thai PCI registry is one of Thailand’s largest statewide current PCI datasets, with 2099 patients aged 80 years, or 9.2% of the total 22 741 PCI patients, or as high as 18.7% for patients 75 or older. This result is greater than the Malaysian NCVD-PCI registry, which reported that around 1% of the 24 469 PCI patients were octogenarians.27 This database was more extensive than the previous research based on Thai National Percutaneous Coronary Intervention Registry (TPCIR) data between 2006 and 2007, with 639 patients, or 15.7% of the total 4156 patients, designated as old by age 75 years. This group’s mean age was 79 years, compared with 80.8 years in our present study.21 The more significant percentage of older patients reflected improved access to basic healthcare, increased PCI-capable facilities and Thailand’s expanding elderly population over the last decades. Thailand’s current health policies on the Universal Coverage Scheme and Universal Coverage for Emergency Patients programme allow all Thai elderly patients free access to coronary intervention in elective and emergency PCIs if they do not have any other healthcare coverage. However, people who use the national universal healthcare programme have fewer treatment options or access to particular medications, such as newer P2Y12 inhibitors or anticoagulants.

According to our registry, sex influences the incidence of CAD in different age groups. Although the majority of the patients enrolled in the research were men, the percentage of PCI in women rose significantly after menopause, with over half of the cases occurring in octogenarians. The sex-specific risk factors for CAD at genetic and epigenetic levels28 29 may have less influence on the elderly population.

According to our data, most octogenarians underwent PCI due to ACS rather than CCS. While NSTE-ACS was significantly more common than STEMI, STEMI remained prevalent among octogenarians, leading to a higher incidence of cardiogenic shock requiring MCS, arrhythmogenic complications, mechanical myocardial infarction sequelae and ultimately an increased risk of death. Nevertheless, the majority of studies and meta-analyses supported primary PCI for this elderly patient population.30 31 32 The results also confirmed the feasibility and mortality benefit of PCI in senior subpopulations with NSTE-ACS.33 34 35 Surprisingly, CCS-indicated PCI accounted as much as 36.9% of octogenarians despite a history of poor outcomes. Unsurprisingly, the elderly had a higher incidence of multivessel coronary artery disease, ostial lesions and calcified lesions, necessitating more complex PCIs and coronary atherectomy. However, the lesion complexity in this PCI registration based on the ACC/AHA categorisation did not reflect actual practice. Due to the nature of the PCI registry, many complex coronary patients were not included in the research, as they were instead referred for coronary bypass revascularisation or managed medically. Advances in the contemporary PCI methods and experience with senior populations have improved safety and outcomes for CCS-indicated PCI. In elective PCI cases such as CCS, the risks and benefits should be thoroughly discussed with patients. PCI should only be performed when there is favourable supporting evidence for patients.

Despite the 2020 Thai Acute Coronary Syndromes guideline recommendation that novel P2Y12 inhibitors be the first-line P2Y12 inhibitor unless there is a higher risk of bleeding,36 dual antiplatelet therapy with aspirin and clopidogrel remained the treatment of choice in octogenarians and non-octogenarians. The treatment choice might be related to the universal coverage policy, payment issues and the availability of innovative P2Y12 inhibitors outside of major metropolitan institutions. Patients with Thai national universal coverage were prohibited from taking prasugrel during data collection.

Given the baseline characteristic, the intricacy of the lesion, the degree of lesion calcification and the patients’ ageing variables, death and PCI complications were greater in octogenarians. PCI in the elderly presents a higher risk of intervention and complications. These findings contradict the prior TPCIR data,21 which found no age effect on in-hospital mortality following PCI. When compared with non-octogenarians, octogenarians had higher periprocedural complications and worse short-term outcomes after myocardial infarction.

With the current PCI techniques and instruments available in most PCI facilities in Thailand, PCI for octogenarians may have a high success rate of up to 95.5%. Our study found that PCI enhanced the quality of life for both octogenarians and non-octogenarians, even in the short period of time before hospital discharge. However, the success rate remained lower than the data from the J-PCI (Japanese Percutaneous Coronary Intervention) registry,37 38 which reported a PCI success rate of over 98% among patients over 80. Nevertheless, ageing did increase the risk of PCI mortality, cardiogenic shock and bleeding complications and is associated with more complex and calcified lesions, as indicated in the Thai PCI registry. The rate of radial approach in the J-PCI registry was over 66%, almost twice the 34% reported in the Thai PCI registry, and was linked to lower hospital mortality and reduced bleeding complications in these groups of patients. This highlights one solution for improving PCI quality in developing countries by increasing the adoption of the transradial approach among octogenarian patients, despite some concerns regarding the tortuosity of the subclavian artery and difficulty in obtaining radial access in the elderly population.

Limitations

Our research has a few limitations. This registry includes individuals who had PCI in 39 cardiac catheterisation facilities. As a result, there is a selection bias that may not represent the entire population of octogenarians with cardiovascular disease. Some individuals may have undergone CABG or medical treatment and were not included in the registry. There may be unmeasured confounders that influence clinical outcomes. Another significant limitation of the Thai PCI registry is no data on frailty, which is important for patient evaluation in the elderly group and might substantially influence patient outcomes.

Conclusions

The Thai PCI registry focuses on real-world practice data on persons over the age of 80 in Thailand. When compared with non-octogenarians, octogenarians experienced more difficult PCI, a greater risk of PCI complications and unfavourable in-hospital mortality. Nonetheless, PCI in the octogenarians had a high success rate and potentially improved the patient’s quality of life. Given the increasingly ageing population, further research into octogenarians will be essential to determine the optimal approach for revascularisation and treatment in this patient group.

Supplementary material

online supplemental file 1
bmjopen-15-4-s001.docx (770.3KB, docx)
DOI: 10.1136/bmjopen-2024-086945

Acknowledgements

We would like to thank Mr. Bryan Roderick Hamman for assistance with the English-language presentation of the manuscript.

Footnotes

Funding: The Thai PCI registry was supported by funding from The Health Systems Research Institute, Thailand.

Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-086945).

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Not applicable.

Ethics approval: This study involves human participants and ethics approval was obtained from CREC (COA-CREC 006/2018) by the Central Research Ethical Committee of the Foundation for Human Research Promotion in Thailand (HRPT) (https://www.crecthailand.org). Local ethics approval was also obtained at each registry site according to their specific requirements. Details on ethics approval are also mentioned in the Thai PCI study design (Sansanayudh et al. J Med Assoc Thai 2021). Participants gave informed consent to participate in the study before taking part.

Map disclaimer: The depiction of boundaries on this map does not imply the expression of any opinion whatsoever on the part of BMJ (or any member of its group) concerning the legal status of any country, territory, jurisdiction or area or of its authorities. This map is provided without any warranty of any kind, either express or implied.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Data availability statement

Data are available upon reasonable request.

References

  • 1.Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052–90. doi: 10.1016/S0140-6736(18)31694-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.United Nations . World population ageing 2019 highlights. 2019. [Google Scholar]
  • 3.World Bank data . Thailand’s life expectancy at birth. 2016. [Google Scholar]
  • 4.World Health Organization . Thailand’s life expectancy at birth m/f. 2016. [Google Scholar]
  • 5.Avezum A, Makdisse M, Spencer F, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE) Am Heart J. 2005;149:67–73. doi: 10.1016/j.ahj.2004.06.003. [DOI] [PubMed] [Google Scholar]
  • 6.Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135:e146–603. doi: 10.1161/CIR.0000000000000485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Madhavan MV, Gersh BJ, Alexander KP, et al. Coronary Artery Disease in Patients ≥80 Years of Age. J Am Coll Cardiol. 2018;71:2015–40. doi: 10.1016/j.jacc.2017.12.068. [DOI] [PubMed] [Google Scholar]
  • 8.Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417–22. [PubMed] [Google Scholar]
  • 9.Forman DE, Rich MW, Alexander KP, et al. Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol. 2011;57:1801–10. doi: 10.1016/j.jacc.2011.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Al-Khadra Y, Kajy M, Idris A, et al. Comparison of Outcomes After Percutaneous Coronary Interventions in Patients of Eighty Years and Above Compared With Those Less Than 80 Years. Am J Cardiol. 2019;124:1372–9. doi: 10.1016/j.amjcard.2019.07.055. [DOI] [PubMed] [Google Scholar]
  • 11.Gerber RT, Arri SS, Mohamed MO, et al. Age is not a bar to PCI: Insights from the long-term outcomes from off-site PCI in a real-world setting. J Interv Cardiol. 2017;30:347–55. doi: 10.1111/joic.12400. [DOI] [PubMed] [Google Scholar]
  • 12.Marcolino MS, Simsek C, de Boer SPM, et al. Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. EuroIntervention. 2012;8:920–8. doi: 10.4244/EIJV8I8A141. [DOI] [PubMed] [Google Scholar]
  • 13.Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol. 2001;38:736–41. doi: 10.1016/s0735-1097(01)01432-2. [DOI] [PubMed] [Google Scholar]
  • 14.Dai X, Busby-Whitehead J, Forman DE, et al. Stable ischemic heart disease in the older adults. J Geriatr Cardiol. 2016;13:109–14. doi: 10.11909/j.issn.1671-5411.2016.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44–164. doi: 10.1016/j.jacc.2012.07.013. [DOI] [PubMed] [Google Scholar]
  • 16.Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016;387:1057–65. doi: 10.1016/S0140-6736(15)01166-6. [DOI] [PubMed] [Google Scholar]
  • 17.Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2570–89. doi: 10.1161/CIRCULATIONAHA.107.182616. [DOI] [PubMed] [Google Scholar]
  • 18.Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2549–69. doi: 10.1161/CIRCULATIONAHA.107.182615. [DOI] [PubMed] [Google Scholar]
  • 19.Kurniawan E, Ding F-H, Zhang Q, et al. Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention. J Geriatr Cardiol. 2016;13:733–9. doi: 10.11909/j.issn.1671-5411.2016.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rich MW. Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. Am J Geriatr Cardiol. 2006;15:7–11. doi: 10.1111/j.1076-7460.2006.05273.x. [DOI] [PubMed] [Google Scholar]
  • 21.Kiatchoosakun S, Keelapang P, Kaewsuwana P, et al. Percutaneous coronary intervention in the elderly: results from the Thai National Percutaneous Coronary Intervention Registry (TPCIR) EuroIntervention. 2010;6:611–5. doi: 10.4244/EIJV6I5A102. [DOI] [PubMed] [Google Scholar]
  • 22.Krittayaphong R, Boonbaichaiyapruck S, Kiatchoosakun S, et al. Demographics and Outcomes of Percutaneous Coronary Intervention in Thailand: Data from Thai Percutaneous Coronary Intervention Registry. J Med Assoc Thai. 2017;100:270–9. [PubMed] [Google Scholar]
  • 23.Sansanayudh N, Chandavimol M, Srimahachota S, et al. Patient Characteristics, Procedural Details, and Outcomes of Contemporary Percutaneous Coronary Intervention in Real-World Practice: Insights from Nationwide Thai PCI Registry. J Interv Cardiol. 2022;2022:5839834. doi: 10.1155/2022/5839834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sansanayudh NSS, Srimahachota S, Chandavimol M, et al. Multi-center, prospective, nation-wide coronary angioplasty registry in Thailand (Thai PCI Registry): registry design and rationale. J Med Assoc Thai. 2021;104:1678–85. doi: 10.35755/jmedassocthai.2021.10.13066. [DOI] [Google Scholar]
  • 25.Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193–202. doi: 10.1161/01.cir.82.4.1193. [DOI] [PubMed] [Google Scholar]
  • 26.EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9. [DOI] [PubMed] [Google Scholar]
  • 27.Ahmad WAW, Ali RM, Khanom M, et al. The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: a summary of three years report. Int J Cardiol. 2013;165:161–4. doi: 10.1016/j.ijcard.2011.08.015. [DOI] [PubMed] [Google Scholar]
  • 28.Haider A, Bengs S, Luu J, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41:1328–36. doi: 10.1093/eurheartj/ehz898. [DOI] [PubMed] [Google Scholar]
  • 29.Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24–34. doi: 10.1093/eurheartj/ehv598. [DOI] [PubMed] [Google Scholar]
  • 30.de Boer SPM, Barnes EH, Westerhout CM, et al. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. Am Heart J. 2011;161:500–7. doi: 10.1016/j.ahj.2010.11.022. [DOI] [PubMed] [Google Scholar]
  • 31.Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J. 2011;32:51–60. doi: 10.1093/eurheartj/ehq375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Antonsen L, Jensen LO, Terkelsen CJ, et al. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: from the Western Denmark heart registry. Catheter Cardiovasc Interv. 2013;81:912–9. doi: 10.1002/ccd.24591. [DOI] [PubMed] [Google Scholar]
  • 33.Kolte D, Khera S, Palaniswamy C, et al. Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI. Am J Med. 2013;126:1076–83. doi: 10.1016/j.amjmed.2013.07.024. [DOI] [PubMed] [Google Scholar]
  • 34.Devlin G, Gore JM, Elliott J, et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J. 2008;29:1275–82. doi: 10.1093/eurheartj/ehn124. [DOI] [PubMed] [Google Scholar]
  • 35.Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004;141:186–95. doi: 10.7326/0003-4819-141-3-200408030-00007. [DOI] [PubMed] [Google Scholar]
  • 36.Vlaar PJ, Lennon RJ, Rihal CS, et al. Drug-eluting stents in octogenarians: early and intermediate outcome. Am Heart J. 2008;155:680–6. doi: 10.1016/j.ahj.2007.11.007. [DOI] [PubMed] [Google Scholar]
  • 37.Otowa K, Kohsaka S, Sawano M, et al. One-year outcome after percutaneous coronary intervention in nonagenarians: Insights from the J-PCI OUTCOME registry. Am Heart J. 2022;246:105–16. doi: 10.1016/j.ahj.2022.01.004. [DOI] [PubMed] [Google Scholar]
  • 38.Numasawa Y, Inohara T, Ishii H, et al. Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry) J Am Heart Assoc. 2019;8:e011183. doi: 10.1161/JAHA.118.011017. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    online supplemental file 1
    bmjopen-15-4-s001.docx (770.3KB, docx)
    DOI: 10.1136/bmjopen-2024-086945

    Data Availability Statement

    Data are available upon reasonable request.


    Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

    RESOURCES